All companies
Centene logo

What smart money is saying about CenteneUnited States flag

CNC · Healthcare · Medical - Healthcare Plans · Market cap $31.64B

3 funds in our archive have pitched Centene — most recently Harris Associates U.S. Concentrated Strategy in June 2026.

Company profile

Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.

Get an email when a fund writes about it

Summarize with Warren AI
3
Reported positions
0
Bought
0
Sold
5
Letters

Position history

Between Q4 2024 and Q2 2026, 3 fund letters reported a position in Centene, with no move described.

Fund letters reporting a position in Centene, by quarter
QuarterLettersBoughtSoldTheses
Q2 20263001
Q1 20260001
Q4 20240001

Fund activity · 3 positions

  • HoldsPacker & Co Investigator Trust
    June 2026

    Listed in Packer & Co Investigator Trust’s reported holdings.

    Read the letterCentene
  • HoldsHarris Associates U.S. Concentrated Strategy
    June 2026
    • Centene was a contributor during the quarter.
    Read the letterCentene
  • HoldsHotchkis & Wiley Mid‑Cap Value Strategy
    June 2026
    Centene outperformed sharply this quarter as adjusted EPS beat consensus by 48%, management raised full-year guidance, and investors gained confidence that the Medicaid margin recovery and ACA membership reset were both tracking ahead of plan.
    Read the letterCentene

Fund coverage · 3 theses

  • Harris Associates U.S. Concentrated Strategy
    June 2026

    Centene is a government managed care leader with expected earnings recovery from stabilizing medical costs, better reimbursement, and expense initiatives.

    Read the full thesis
  • Oakmark Equity and Income Fund
    March 2026

    Centene Corporation is the leading government managed care provider with scale advantages and cyclical margin recovery potential at a discounted valuation.

    Read the full thesis
  • Greenlight Capital
    December 2024

    CNC is trading at a historically low valuation despite its status as the largest Managed Medicaid company, with potential for significant repricing in its core Medicaid business over the next two years amidst current concerns.

    Read the full thesis

Read every full thesis on Centene

Unlock all 3 theses — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.

View plans
Share this ledger